DISCLOSEDQuarterly
Duquesne Family Office
Monte Rosa Therapeutics Inc · NASDAQ
297,600 sh · $7.2M
Filed 30 Jun 2026SEC 13Fview source
Duquesne Family Office
Monte Rosa Therapeutics Inc · NASDAQ
297,600 sh · $7.2M
Two Sigma Investments
Monte Rosa Therapeutics Inc · NASDAQ
19,300 sh · $317.5K
Renaissance Technologies
Monte Rosa Therapeutics Inc · NASDAQ
379,100 sh · $6.2M
BlackRock
Monte Rosa Therapeutics Inc · NASDAQ
2,360,093 sh · $8.8M